Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.
Related Posts
H2O.ai Just Released Its Latest Open-Weight Small Language Model, H2O-Danube3, Under Apache v2.0
The natural language processing (NLP) field rapidly evolves, with small language models gaining prominence. These models, designed for efficient inference…
RL^V: Unifying Reasoning and Verification in Language Models through Value-Free Reinforcement Learning
LLMs have gained outstanding reasoning capabilities through reinforcement learning (RL) on correctness rewards. Modern RL algorithms for LLMs, including GRPO,…
How Memory Transforms AI Agents: Insights and Leading Solutions in 2025
The importance of memory in AI agents cannot be overstated. As artificial intelligence matures from simple statistical models to autonomous agents, the…